In conclusion, tumor SOX30 negatively associates with LYN metastasis, T stage, N stage, and TNM stage while positively relates to accumulating OS in CRC patients, suggesting SOX30 might be a possible biomarker of progression and prognosis of CRC. This evidence concerns the gene SOX30 and colorectal carcinoma.